Advertisement
DMRA vs GNTA
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DMRA is a Buy and GNTA is a Hold.
DMRA in upward trend: price may jump up because it broke its lower Bollinger Band on October 13, 2026
DMRA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 34 of 36 cases where DMRA's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 90%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where DMRA's RSI Indicator exited the oversold zone, 26 of 29 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 90%.
The Momentum Indicator moved above the 0 level on October 20, 2026. You may want to consider a long position or call options on DMRA as a result. In 75 of 88 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 85%.
The Moving Average Convergence Divergence (MACD) for DMRA just turned positive on October 07, 2026. Looking at past instances where DMRA's MACD turned positive, the stock continued to rise in 39 of 47 cases over the following month. The odds of a continued upward trend are 83%.
Following a +5.03% 3-day Advance, the price is estimated to grow further. Considering data from situations where DMRA advanced for three days, in 205 of 237 cases, the price rose further within the following month. The odds of a continued upward trend are 86%.
Bearish Trend Analysis
The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.
The 50-day moving average for DMRA moved below the 200-day moving average on October 15, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where DMRA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 86%.
The Aroon Indicator for DMRA entered a downward trend on October 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 2 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.472) is normal, around the industry mean (2.973). DMRA has a moderately low P/E Ratio (-83.500) as compared to the industry average of (-1.705). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (128.121) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (438.009).
The Tickeron PE Growth Rating for this company is 14 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 42 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock slightly better than average.
The Tickeron Price Growth Rating for this company is 44 (best 1 - 100 worst), indicating steady price growth. DMRA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
GNTA's MACD Histogram just turned positive
The Moving Average Convergence Divergence (MACD) for GNTA turned positive on September 25, 2026. Looking at past instances where GNTA's MACD turned positive, the stock continued to rise in 52 of 60 cases over the following month. The odds of a continued upward trend are 87%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where GNTA's RSI Indicator exited the oversold zone, 25 of 32 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 78%.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 6 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +8.77% 3-day Advance, the price is estimated to grow further. Considering data from situations where GNTA advanced for three days, in 151 of 185 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on October 14, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on GNTA as a result. In 106 of 118 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.
The 50-day moving average for GNTA moved below the 200-day moving average on September 29, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where GNTA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for GNTA entered a downward trend on October 21, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 8 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 22 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.782) is normal, around the industry mean (-0.788). P/E Ratio (-1.703) is within average values for comparable stocks, (16.776). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (0.772). Dividend Yield (0.000) settles around the average of (543.841) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (2.059).
The Tickeron Price Growth Rating for this company is 84 (best 1 - 100 worst), indicating slightly worse than average price growth. GNTA’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 96 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. GNTA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 82, placing this stock worse than average.
DMRA | ||
|---|---|---|
OUTLOOK RATING 1..100 | 12 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 2 Undervalued | |
PROFIT vs RISK RATING 1..100 | 42 | |
SMR RATING 1..100 | 99 | |
PRICE GROWTH RATING 1..100 | 44 | |
P/E GROWTH RATING 1..100 | 14 | |
SEASONALITY SCORE 1..100 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| DMRA | GNTA | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 90% | 1 day ago 78% |
| Stochastic ODDS (%) | 1 day ago 90% | 1 day ago 82% |
| Momentum ODDS (%) | 1 day ago 85% | 1 day ago 90% |
| MACD ODDS (%) | 1 day ago 83% | 1 day ago 87% |
| TrendWeek ODDS (%) | 1 day ago 86% | 1 day ago 90% |
| TrendMonth ODDS (%) | 1 day ago 87% | 1 day ago 90% |
| Advances ODDS (%) | 1 day ago 86% | 18 days ago 82% |
| Declines ODDS (%) | 10 days ago 86% | 10 days ago 90% |
| BollingerBands ODDS (%) | 1 day ago 90% | N/A |
| Aroon ODDS (%) | 1 day ago 82% | 1 day ago 90% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
DMRA’s FA Score shows that 2 FA rating(s) are green while GNTA’s FA Score has 2 green FA rating(s).
- DMRA’s FA Score: 2 green, 3 red.
- GNTA’s FA Score: 2 green, 3 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
DMRA’s TA Score shows that 5 TA indicator(s) are bullish while GNTA’s TA Score has 4 bullish TA indicator(s).
- DMRA’s TA Score: 5 bullish, 4 bearish.
- GNTA’s TA Score: 4 bullish, 4 bearish.
Price Growth
DMRA (@Biotechnology) experienced а +15.85% price change this week, while GNTA (@Industrial Conglomerates) price change was -5.87% for the same time period.
The average weekly price growth across all stocks in the @Biotechnology industry was +1.32%. For the same industry, the average monthly price growth was -16.33%, and the average quarterly price growth was -16.65%.
The average weekly price growth across all stocks in the @Industrial Conglomerates industry was -3.17%. For the same industry, the average monthly price growth was -9.37%, and the average quarterly price growth was -15.30%.
Reported Earning Dates
DMRA is expected to report earnings on Nov 05, 2026.
Industries' Descriptions
@Biotechnology (+1.32% weekly)Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
@Industrial Conglomerates (-3.17% weekly)Industrial Conglomerates specialize in numerous types of products, most of which comprise industrial goods, while some also go towards meeting household needs. Honeywell (makes engineering services and aerospace systems), United Technologies Corporation(manufactures aircraft engines, aerospace systems, HVAC, elevators and escalators, fire and security, building systems, and industrial products, among others), 3M (over 60,000 products under several world-renowned brands, including adhesives, abrasives, laminates, passive fire protection, personal protective equipment, window films, paint protection films, dental and orthodontic products, electrical & electronic connecting and insulating materials, medical products, car-care products, electronic circuits, healthcare software and optical films).
Advertisement
DMRA and
Correlation & Price change
A.I.dvisor indicates that over the last year, DMRA has been closely correlated with COGT. These tickers have moved in lockstep 75% of the time. This A.I.-generated data suggests there is a high statistical probability that if DMRA jumps, then COGT could also see price increases.
| Ticker / NAME | Correlation To DMRA | 1D Price Change % | ||
|---|---|---|---|---|
| DMRA | 100% | +0.84% | ||
| COGT - DMRA | 75% Closely correlated | -0.38% | ||
| NERV - DMRA | 45% Loosely correlated | +0.42% | ||
| INBX - DMRA | 44% Loosely correlated | -1.11% | ||
| RANI - DMRA | 44% Loosely correlated | -2.88% | ||
| GNTA - DMRA | 38% Loosely correlated | -1.55% | ||
More | ||||